Imagen de Portada

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Shaohui Wang, Sa Guo, Jing Guo, Qinyun Du, Cen Wu, Yeke Wu, Yi Zhang
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	MedComm
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets
por: Shen'er Qian, et al.
Publicado: (2024)

Cellular senescence in cancer: molecular mechanisms and therapeutic targets
por: Ping Jin, et al.
Publicado: (2024)

Regulation of bone homeostasis: signaling pathways and therapeutic targets
por: Zebin Wu, et al.
Publicado: (2024)

Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
por: Xiangpeng Wang, et al.
Publicado: (2024)

Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
por: Ayesha Nisar, et al.
Publicado: (2024)

Posttransplant complications: molecular mechanisms and therapeutic interventions
por: Xiaoyou Liu, et al.
Publicado: (2024)

Ferroptosis: mechanisms and therapeutic targets
por: Qian Zhou, et al.
Publicado: (2024)

Tumor‐associated exosomes in cancer progression and therapeutic targets
por: Xiaomin Liu, et al.
Publicado: (2024)

Liver cirrhosis: molecular mechanisms and therapeutic interventions
por: Zihe Dong, et al.
Publicado: (2024)

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
por: Lu Zhao, et al.
Publicado: (2024)

Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
por: Yuxi Ma, et al.
Publicado: (2024)

Renal cancer: signaling pathways and advances in targeted therapies
por: Aimin Jiang, et al.
Publicado: (2024)

Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer
por: Yufeng Li, et al.
Publicado: (2024)

Comprehensive multi‐omics analysis provides biological insights and therapeutic strategies for small‐cell lung cancer
por: Guo Zhao, et al.
Publicado: (2024)

Protein palmitoylation: biological functions, disease, and therapeutic targets
por: Yan‐Ran Qian, et al.
Publicado: (2025)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
por: Xiaoting Luo, et al.
Publicado: (2024)

Disulfidptosis: disulfide stress‐induced novel cell death pathway
por: You Shuai, et al.
Publicado: (2024)

Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
por: Yunhan Tan, et al.
Publicado: (2025)

Heat shock protein 90: biological functions, diseases, and therapeutic targets
por: Huiyun Wei, et al.
Publicado: (2024)

Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
por: Tian‐Hua Wei, et al.
Publicado: (2024)

Innate immunity in diabetic nephropathy: Pathogenic mechanisms and therapeutic targets
por: Le‐Xin Chen, et al.
Publicado: (2024)

The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
por: Jian Tang, et al.
Publicado: (2024)

Serotonin signaling: a new player and therapeutic target beyond Long‐haul coronavirus disease
por: Lan Bai, et al.
Publicado: (2024)

Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities
por: Zi‐Han Yang, et al.
Publicado: (2024)

Full‐active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing
por: Xianghui Li, et al.
Publicado: (2024)

Endothelial dysfunction: molecular mechanisms and clinical implications
por: Xia Wang, et al.
Publicado: (2024)

Tissue‐resident memory T cells in diseases and therapeutic strategies
por: Daoyuan Xie, et al.
Publicado: (2025)

cGAS–STING, an important signaling pathway in diseases and their therapy
por: Qijie Li, et al.
Publicado: (2024)

Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances
por: Yunxuan Jia, et al.
Publicado: (2024)

Redox regulation of cancer stem cells: Biology and therapeutic implications
por: Min Du, et al.
Publicado: (2024)

Targeting esophageal carcinoma: molecular mechanisms and clinical studies
por: Wenjing Wang, et al.
Publicado: (2024)

Inducing disulfidptosis in tumors:potential pathways and significance
por: Tao Mi, et al.
Publicado: (2024)

Metabolic regulation of intestinal homeostasis: molecular and cellular mechanisms and diseases
por: Ruolan Zhang, et al.
Publicado: (2024)

Ocular immune‐related diseases: molecular mechanisms and therapy
por: Yakun Wang, et al.
Publicado: (2024)

Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
por: Jiangchun Wu, et al.
Publicado: (2024)

Anoikis in cell fate, physiopathology, and therapeutic interventions
por: Jie Mei, et al.
Publicado: (2024)

Targeting werner helicase with synthetic lethality in microsatellite instability cancers: Promising therapeutic approaches
por: Huanzhang Xie, et al.
Publicado: (2024)

5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
por: Jianhua Xia, et al.
Publicado: (2024)

Inducible T Cell Costimulator Ligand and Inducible T Cell Costimulator Stratification Identify Dichotomous Tumor Microenvironment and Guide Chemo‐Immunotherapy in Small Cell Lung Cancer
por: Qiji Guo, et al.
Publicado: (2026)

Circular RNAs in cancer
por: Yang Guo, et al.
Publicado: (2025)